Back to School: How biopharma can reboot drug development. Access exclusive analysis here

SangStat news

SANG (Menlo Park, Calif.) formed XenoStat Inc., a wholly owned subsidiary, to develop drugs to promote acceptance of animal organs by human

Read the full 225 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE